C
Citius Oncology, Inc. (CTOR)
0.51
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
0.51
0.00 (0.00%)
Citius Oncology, Inc. innovatsion maqsadli onkologiya terapiyalarini ishlab chiqish va tijoratlashtirishga qaratilgan. Kompaniya, shuningdek, nodir kasallik - qaytalangan yoki refrakter teri T-hujayrali limfomasi, noto'g'ri limfomaning kam uchraydigan shakli - kattalar bemorlarini davolash uchun LYMPHIRni ishlab chiqish bilan shug'ullanadi. Kompaniya shtab-kvartirasi Cranford, Nyu-Jersi shahrida joylashgan. Citius Oncology, Inc. Leonard-Meron Biosciences, Inc.ning sho'ba korxonasidir.
| Ism | Lavozim |
|---|---|
| Dr. Myron S. Czuczman M.D. | Executive VP & Chief Medical Officer |
| Mr. Jaime Bartushak | Chief Financial Officer & Treasurer |
| Mr. Leonard L. Mazur | CEO, President & Executive Chairman |
| Mr. Myron Z. Holubiak | Secretary & Executive Vice Chairman |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-10 | 8-K | ea0280663-8k_citius.htm |
| 2026-03-04 | 8-K | ea0277423-8k_citius.htm |
| 2026-01-29 | DEF 14C | ea0274187-def14c_citius.htm |
| 2026-01-05 | S-3 | ea0271642-s3_citius.htm |
| 2025-12-23 | 8-K | ea0270775-8k_citius.htm |
| 2025-12-10 | 8-K | ea0269093-8k_citius.htm |
| 2025-12-01 | 8-K | ea0267560-8k_citius.htm |
| 2025-10-27 | 8-K | ea026265801-8k_citiusonc.htm |
| 2025-10-23 | 8-K | ea0262328-8k_citiusonc.htm |
| 2025-09-26 | DEF 14A | ea0257805-def14a_citius.htm |